Elise Leger
Obstetrics & Gynecology · Greensboro, NCNPI 1346582624
Payments from drug & device makers
Across 198 payments — averaging $16.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$742
- Mayne Pharma Commercial LLC$428
- Astellas Pharma US Inc$240
- Evofem Biosciences, Inc.$157
- Exeltis, USA Inc.$156
- Biogen$126
- plus $1K from 31 others
What the payments were for
- Food & beverage$3,16099%
- Education$261%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 44 | $742 |
| Mayne Pharma Commercial LLC | 20 | $428 |
| Astellas Pharma US Inc | 19 | $240 |
| Evofem Biosciences, Inc. | 13 | $157 |
| Exeltis, USA Inc. | 10 | $156 |
| Biogen | 5 | $126 |
| Avion Pharmaceuticals | 6 | $100 |
| Myovant Sciences Inc. | 5 | $97 |
| Therapeuticsmd, Inc. | 7 | $94 |
| Pfizer | 6 | $86 |
| Bayer | 6 | $83 |
| Shield Therapeutics Inc | 5 | $75 |
| Sumitomo Pharma America, Inc. | 4 | $71 |
| Lilly USA, LLC | 4 | $58 |
| Agile Therapeutics, Inc. | 3 | $53 |
| Millicent US Inc | 3 | $49 |
| Merck | 4 | $49 |
| Organon | 3 | $48 |
| Novo Nordisk | 3 | $45 |
| Davol Inc. | 2 | $43 |
| Biohaven Pharmaceuticals, Inc. | 2 | $41 |
| Mylan Pharmaceuticals Inc. | 3 | $38 |
| Pacira Pharmaceuticals Incorporated | 2 | $35 |
| Eisai Inc. | 2 | $29 |
| Currax Pharmaceuticals LLC | 2 | $29 |
| Daiichi Sankyo Inc. | 2 | $26 |
| Vertical Pharmaceuticals, LLC | 2 | $26 |
| Duchesnay USA Incorporated | 2 | $25 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Roche Diagnostics Corporation | 1 | $18 |
| Lupin Inc. | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Mallinckrodt Enterprises LLC | 1 | $13 |
| Mission Pharmacal Company | 1 | $12 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
| Meditrina | 1 | $9 |
How this compares
$3,186 in reported general payments places this provider in the 80th percentile of 1,344 obstetrics & gynecology providers in North Carolina.
See all obstetrics & gynecology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 19 | $1,027 |
| Clobetasol Propionate | 11 | $190 |
| Alendronate Sodium | 19 | $63 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Greensboro
- Mark AndersonGreensboro$455K
- Laura McKainWilmington$2.6M
- Robert ParkerWinston-Salem$2.1M
- Allison PuechlCharlotte$1.6M
- Jeffrey MichelsonNew Bern$1.2M
- Robert LittletonRaleigh$976K
- Donald HornerCharlotte$907K
- Rebecca Dunsmoor SuMorrisville$837K
- Ann CollinsRaleigh$701K
- Kathryn PattenHendersonville$550K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.